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Abstract 
 
 
The application of Zingiber officinalis (ginger) root extract as a complementary therapy for 
several pathological conditions, and its major use in current western medicine has been 
described, as well as its common application in Traditional Chinese Medicine.  
The phytochemical characterization of the natural active compounds present in ginger 
reflects its major healthy actions, and allows the perception of its several mechanisms of 
action on several pathologies. 
Owning several chemical constituents with strong and assessed properties, a fourteen-day 
case study trial was performed using ginger root powdered capsules in order to evaluate its 
anti-inflammatory effect and compare it with a commonly prescribed non-steroidal-anti-
inflammatory drug (ibuprofen) on patients suffering from chronic muscular pain, through the 
collection of subjective data provided throughout the study. 
 
Keywords: Zingiber officinalis, Traditional Chinese Medicine, complementary medicine, 
ibuprofen, NSAIDs, anti-inflammatory, mechanisms of action, muscular pain. 
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Introductory Note 
 
The terminology used in Traditional Chinese Medicine is based on the extensive work of 
Professor Manfred Porkert (Porkert, M. 1983), and is adopted in the Masters Degree of 
Traditional Chinese Medicine at Biomedical Sciences Institute of Abel Salazar, University of 
Porto. 
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Chapter I - Introduction 
 
The support of the Plant Kingdom goes back to ancient times, practically inserted in all types 
of cultures and civilizations, as a medicinal, nutritional, cultural and aesthetical source, 
described in several ancient manuscripts, as for example the Bible, in which plants were 
designated as “creators offers”, and seen with great respect and amazement (Hoareau & Da 
Silva, 1999).  
 
The great incidence of aromatic plants in China and India lead to the extraction of essential 
oils, whose application in ointment preparations and balms had cosmetic goals (D’Amelio, 
1999). 
 
The rhizome of Zingiber officinalis is one of the most widely used species of the ginger 
family (Zingiberaceae) and is a common condiment for various foods and beverages. Ginger 
has a long history of herbal medicinal use dating back 2,500 years in China and India for the 
treatment of conditions such as headaches, nausea, rheumatism, nervous diseases, 
toothache, constipation, diabetes and colds. Characterized in Traditional Chinese Medicine 
as spicy and hot, ginger is claimed to warm the body and treat cold extremities, improve a 
weak and tardy pulse, address a pale complexion, and strengthen the body after blood loss 
which reflect its popularity and common use as a spice and medicinal plant (Ali, B. et al., 
2008). 
 
In Europe, ginger was firstly listed in Galen's pharmacopoeia, and was mentioned by Plinius 
the Elder for medicinal use. Since then, ginger has been part of the folk medicine and 
popular nutraceuticals (Bartels, E. et al., 2015). 
 
Regarding Traditional Chinese Medicine, a considerable percentage of chronically ill patients 
(60-80%), regularly complaining about chronic pain, search for help in complementary 
medicine, however, in many places, this kind of medicine is not a major part of medical 
formation. For instance, in Germany, homeopathic and phytopharmacological treatments 
have strong traditions, whereas in other European countries Phytopharmacology has almost 
been abolished and even homeopathic treatment is sometimes close to being forbidden for 
irrational reasons (Greten, H., 2010). So, it is of great consideration to try to integrate TCM 
in the European western medicine in a complementary controlled manner. 
 
The latest scientific developments have allowed the attendance of basic needs 
(nourishment, health and clothing) in a great part of the constantly growing human 
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population (Galembeck, F. & Csordas, Y. 2010; Gediya et al., 2011). Furthermore, the 
“Phytocosmetics” actually represents a sector in clear development, not only due to the 
scientific investigation growth, but also due to the real benefits of the application of plant 
products instead of some synthetic ones, as well as nowadays society requirements on 
adopting economical, ecological and safe production technologies, which in turn require a 
huge effort by investigators in finding distinct, natural and competitive compounds (Draelos, 
Z., 2001; Kole et al., 2005). 
 
Currently, ginger is one of the most popular herbal medications for rheumatic and muscular 
diseases, and its beneficial effects have been previously and continuously described. 
Ibuprofen is usually prescribed as a pain killer in case of inflammations, e.g. muscular pain, 
teeth pain, headaches, menstrual pain and other kinds of pain, however many patients use 
this kind of medication (NSAIDs) for prolonged periods rather than the suitable time of 
treatment, and are unaware of the hazards this may imply due to serious gastric adverse 
manifestations (Bliddal, H. et al., 2000). 
 
Despite the several healthy actions ginger has on the human body, chronic muscular pain 
has not been extensively reviewed, so it is of great importance to evaluate the efficacy of 
ginger root powdered capsules on the relief of chronic muscular pain on the leg, and to 
compare it with ibuprofen, a commonly prescribed NSAID, known to have several side 
effects, mainly stomach pain. 
 
In this context, the aim of the present study was to assess the anti-inflammatory efficacy of 
ginger root powdered capsules provided from Solgar®, certificated manufacturers of 
multivitamin supplements since 1947 (through the evaluation of subjective data) and its 
tolerability, and compare it to one of the most commonly prescribed drugs for muscular pain  
- ibuprofen, known to be reasonably efficient and owning side effects. 
 
 
 
 
 
 
 
 
 
Complementary Therapy with Zingiber officinalis – clinical cases	
	 13 
Chapter II – Health impact – clinical case: comparison of commonly used NSAID – 
ibuprofen - with ginger root powdered capsules on chronic muscular pain 
 
Summary 
 
Background: The seek for alternative therapies has been extensively increasing by patients 
with chronic muscular pain, but only few of these drugs have been tested in a controlled 
manner, so the aim of the present study was to compare the efficacy and tolerability, both 
subjectively, of one commonly prescribed drug for muscular pain  - ibuprofen (NSAID) - and 
ginger root powdered capsules provided from Solgar®, certificated manufacturers of 
multivitamin supplements since 1947, being ginger one of the most popular and versatile of 
herbal medications. 
 
Design: the design was a randomised, fourteen-day controlled double-blind study. A 
placebo group (N=3) was included, with volunteers receiving sugar tablets twice a day for 
two weeks, a ginger root powder group (N=3) receiving 450mg of ginger root powdered 
capsules twice a day during 14 days, and finally, an ibuprofen group (N=3) receiving 400mg 
of ibuprofen twice a day during the fourteen-day trial. The main outcome measures were 
none to slight/moderate or total pain relief evaluation on days 1, 7 and 14, as well as 
subjective reports on adverse events. Ginger extract capsules were compared to placebo 
and ibuprofen in patients with chronic muscular pain in the legs. The study was conducted in 
accordance with Good Clinical Practice (European Guideline for GCP). 
 
Results: the follow up was possible in all volunteers. A ranking of efficacy of the 14-day 
treatment trial resides on the following sequence: ibuprofen > ginger > placebo. In each 
active treatment group, all volunteers experienced slight to moderate improvements in 
muscular pain relief, having 1/3 of the volunteers treated with ibuprofen exhibited stomach 
pain as a side effect. The period of treatment showed a better effect of both ibuprofen and 
ginger root powdered extract than placebo. There were no serious adverse events reported 
during the entire period of treatment regarding the active medications, unless some changes 
in stool consistency and nausea (none of them severe), having only 1/3 of the volunteers 
taking ibuprofen reported uncomfortable stomach pain. 
 
Conclusions: ginger root powdered capsules may be recommended for the relief of 
muscular pain, exhibiting less side effects when compared to commonly prescribed NSAIDs 
(e.g. ibuprofen). Further research on this potential activity of ginger is required, as well as a 
larger number of participants. 
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Subjects and Methods 
 
Subjects 
 
After signing an informed consent form, 9 volunteers were selected for the study and told to 
leave current medication for a week, in order to settle the beginning of this trial the week 
after. Patients over 30 years of age and under 70 were eligible for the study. During the 
study, all patients accepted to reach the culmination of the treatment period. Exclusion 
criteria included rheumatoid arthritis, dementia, neurological disorders and severe medical 
diseases, as well as no injections in muscles/joints were accepted within six months before 
the study. 
 
All patients had complaints of pain due to excessive muscular use (e.g. excessive exercise 
in gyms), or due to a sedentary lifestyle (e.g. too much time sitting at the computer) or even 
farming. 
 
Ginger root powdered extract 
 
An extract of selected chinese ginger (Zingiber officinale – Ginger root extract) with a 
standardized content of ginger root powdered extract, owning 15 mg (5%) of ginger phenols, 
was used. The extract was formulated in soft capsules containing hydroxypropylmethyl 
cellulose, which shields the content of ginger. 
 
Design 
 
The trial was conducted in a double-blind controlled study, recruiting 9 volunteers 
complaining about muscular pain. At study entry, treatment with analgesics, NSAIDs and 
other drugs was stopped for a one-week washout period. The patients were then 
randomized to each treatment groups, with either 450 mg of ginger root powdered extract, 
400 mg of ibuprofen or placebo (saccharine tablets). No further washout period was used 
between the 14-day period of study. The patients were randomized in blocks of three, a 
placebo group of volunteers (N=3), receiving saccharine tablets twice a day for fourteen 
days, a ginger root group (N=3) receiving 450mg of ginger root powdered capsules twice a 
day during 14 days, and finally, an ibuprofen group (N=3) receiving 400mg of ibuprofen 
tablets twice a day during the fourteen-day trial fully described in Table 1, all done under 
supervision. The study was conducted in accordance with the Good Clinical Practice 
(European Guidelines for GCP) at Farmácia Diniz Gomes, where patients regularly go for 
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medication supply and where they seek for health advice. No further washout period was 
used between the 14-day period of study. 
 
Table 1 – Study design. 
 
Masking 
 
Both the ginger root extract powdered capsules and the ibuprofen tablets were 
indistinguishable for each patient, and as long as it was intact, the capsule did not release 
any smell or taste of ginger. Additionally, there was no difference in compliance as judged 
from capsule and pill consumption during the entire treatment period. 
 
Assessment of efficacy (Outcome measures) 
 
At the end of each treatment period, the main outcome measures were none to 
slight/moderate or total pain relief evaluation on days 1, 7 and 14, as well as subjective 
reports on adverse events. During each day of evaluation (1, 7 and 14-day of trial) each 
patient was requested to perform a clinical diagnosis through the fulfilment of a clinical case 
sheet, provided from Greten, H. (2010) in Traditional Chinese Medicine classes, which are 
fully filled (taking into account every detail referred from the patients along the trial) on the 
appendix. Finally, the intake of all trial medications was counted at each visit in the presence 
of the patients. 
 
Assessment of safety 
 
All adverse episodes, including changes in taste, were pointed out throughout the study. 
 
 
 
 
 
Active Medication Dose Formula Duration of effect 
Ginger root powder 
450mg of standardised ginger 
root powder extract 
capsules 
Twice a day for 14 
consecutive days Ibuprofen 400mg tablets 
Placebo (saccharine tablets) ≈ 4,4g (teaspoon of sugar) tablets 
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Results 
 
Demographics and Compliance 
 
A total of 9 patients were evaluated, eligible and randomized for the treatment trial. All the 
patients complied with the prescheduled study-visits. Of the 9 patients, 3 were men and 6 
women, 6 had primarily muscular pain due to hard farming, and 3 complained about 
muscular pain due to excessive exercise. The mean age of the patients was 42,4 (range 
between 30-70 years), and the mean duration of muscular pain was 2 weeks. Most of the 
patients had previously consumed NSAIDs, but at the entry of the study, no patient was 
receiving NSAID treatment, or being given injections in muscles/joints within six months 
before the study. 
 
Efficacy (Subjective Data) 
 
The parameters of pain changed during therapy in all periods. The pain scores recorded for 
each patient were evaluated and reproduced filling the clinical sheets previously referred, as 
well as described on Table 2. 
 
Table 2 – Comparison of the efficacies of ginger and ibuprofen on muscular pain complaining 
patients. 
 
Safety 
 
The adverse events were mainly gastrointestinal complaints (placebo period N=2, and 
ibuprofen period N=2), which were characterized as dyspepsia. Other complaints although 
with less intensity but significant were changes in stool consistency (placebo N=2, ginger 
extract N=1 and ibuprofen N=1) or nausea (placebo N=1 and ibuprofen N=1). 
 
 
Medication 
Efficacy 
1-day trial 
pain relief 
7-day trial  
pain relief 
14-day trial 
pain relief Adverse events 
Ginger root (N=3) - slight/moderate moderate change in stool consistency 
Ibuprofen (N=3) slight/moderate slight/moderate total 
dyspepsia 
nausea 
change in stools 
Placebo (N=3) - - - 
dyspepsia,  
nausea, 
muscular pain 
change in stools 
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Discussion and Conclusions 
 
The fourteen-day consented trial demonstrated a subjective efficacy on pain level and 
function in patients with muscular pain of the leg, with ibuprofen being more effective than 
ginger root powdered extract, and also more effective than placebo, with ginger root 
powdered extract group exhibiting a significant subjective efficacy when compared to 
placebo. During the two-week treatment trial only significant gastrointestinal complaints were 
reported (mainly by placebo, and from the ibuprofen test-groups). 
 
Although the use of NSAIDs in muscular pain is controversial, the fact is that many patients 
favour these substances for both short and long-term use. In this study, two thirds of the 
patients were regular NSAID users. 
 
The subjective data obtained may imply that effectively ginger may display anti-inflammatory 
activity at a great level, in comparison to ibuprofen, which correlates with previous studies on 
its anti-inflammatory potential. Furthermore, ginger root group revealed less side effects 
when compared to the ibuprofen group, whose side effects reported were mainly dyspepsia, 
nausea and changes in stool consistency. 
 
The hypothetic anti-inflammatory action of ginger may reside on the action of its 
components, mainly phenols, which are known to act on inflammatory processes. When the 
cellular membrane gets wounded, which is mainly composed of phospholipids, the A2 
phospholipase enzyme, present in leukocytes and platelets, is activated by pro-inflammatory 
cytokines, as for e.g. interleukine-1 (IL-1). In turn, this enzyme leads to the degradation of 
the phospholipidic barrier, resulting in the production of arachidonic acid. This acid is then 
metabolized in chemical messengers like leukotrienes, through the action of the 
lipooxygenase enzyme (LO), and in prostaglandins, prostacyclins and thromboxanes 
through the action of the cyclooxygenase enzyme (COX) (Hilário, M. et al., 2006; 
Tjendraputra, E. et al., 2001; Koo, K. et al., 2001). The entire process can be observed on 
Figure 1. 
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Figure 1 – Scheme of the hypothetic anti-inflammatory action of ginger. 
 
 
 
Since ginger comprises chemical substances (mainly phenols), which appear to inhibit both 
cyclooxygenase and lipoxygenase (dual inhibitors of COX and LOX), it can lead to a lower 
production of chemical messengers like leukotrienes (LTs), tumour necrosis factor (TNF) 
and prostaglandins (PGs), occurring systematically at the site of inflammation, helping with 
pain relief. Thus, this dual action might be interesting in the field of rheumatology and 
orthopaedics (Bliddal et al., 2000; Tjendraputra, E. et al., 2001). A recent study, conducted 
by Tjendraputra, E. et al. (2003), demonstrated that |8|-paradol, a natural constituent of 
ginger, was found to be the most potent COX-1 inhibitor and antiplatelet aggregation agent, 
whose mechanism may be related with the attenuation of the COX-1/Thromboxane synthase 
enzymatic activity. 
 
The two-week period of therapy in this study might not have been sufficient for all effects of 
ginger root powdered extract to be discovered, and only one dose of ginger extract was 
applied. Future studies might look into dose-response and duration of therapy of ginger root 
powdered extract, if possible employing a higher dose of ginger extract. Further research on 
this topic could evaluate the real effect of supplementation of 1 g/daily of ginger root 
capsules on lipid profile, coagulation factors, other inflammatory mediators, and neuronal 
sensitization. Future research can also consider the effect of 1 g/daily ginger capsule on 
oxidative stress-related parameters, and determine whether ginger root extract can be 
recommended for cancer. 
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Chapter III - Zingiber officinalis botanical and phytochemical composition 
 
Native to tropical Asia, especially between India and China, Ginger is a well-known spice 
composed of a knotted, thick, beige underground stem, a rhizome (Figure 2). The stem 
sticks up about 0,6-1,2 meters above ground with long, narrow, ribbed green leaves, and 
white or yellowish-green flowers, growing well in drained argillaceous areas (Proença da 
Cunha, A., 2006; Hasan, H. et al., 2012, Ali, B. et al., 2008, Ojewole, J., 2006). 
 
Figure 2 - Zingiber officinalis botanical illustration by Francisco Manoel Blanco (Spanish botanist). 
Table 3 - Oleoresin relative chemical composition profile of ginger dried rhizome, obtained from High 
Performance Liquid Chromatography (HPLC) (Hasan, H. et al., 2012). 
 
Identified components % peak area in 
methanol 
|6|-gingerol 25% 
zingiberene 9% 
β-bisabolene 4% 
α-farnesene 11% 
|6|-shogaol 18% 
β-sesquiphellandrene 9% 
α-curcumene 14% 
                               Figure 2      Table 3 
 
The constituents of ginger are numerous, and may vary, depending on the place of origin, 
climate and harvest, specie of ginger, maturity of the rhizome, as well as depending whether 
the rhizomes are fresh or dry and preparation method of the extract (Ali, B. et al., 2008; 
Bartels, E. et al., 2015). 
 
Chemically speaking, ginger is absolutely packed with active ingredients as can be seen in 
Table 3. The Materia Medica reports that it includes a essential volatile oil (1-3%), 
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responsible for its characteristic odor, full of sesquiterpenoids (such as zingiberene, α-
curcumene, β-bisabolene, α-farnesene) and monoterpenoids (such as β-sesquiphellandrene 
and camphene), major pungent phenolic principles of the lipophilic rhizome extract 
(gingerols and shogaols, 5-8%), lecithin, proteins, starch (60%), vitamins, minerals, and 
more (Proença da Cunha, A., 2006; Hasan, et al., 2012, Ali, B. et al., 2008; Young, H.-Y. et 
al., 2006). 	
Steam distillation of powdered ginger produces ginger oil, which contains a high proportion 
of sesquiterpenoid hydrocarbons. The pungency of fresh ginger is due primarily to the 
gingerols, which are a homologous series of phenols, and the most abundant compound is 
|6|-gingerol, which appears to be responsible for its characteristic taste, and is commonly 
used as a marker substance of ginger (Alternative Medicine Review, 2003, Young, Y. et al. 
2005; Ali, B. et al., 2008; Young, H.-Y. et al., 2006). In another hand, the pungency of dry 
ginger mainly results from shogaols (mainly |6|-shogaol), which are dehydrated forms of 
gingerols (Ali, B. et al., 2008). 
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Chapter IV – Principal pharmacological properties of ginger, mechanisms of action 
and clinical indications 
 
Nowadays, health care professionals may recommend ginger to help prevent or treat several 
conditions. Ginger has been widely used in Ayurvedic and Chinese medicine to treat 
pathologies like stomach upset, diarrhoea, digestion problems, asthma, diabetes, nausea, 
stroke, rheumatism, osteoarthritis and toothache described in Table 4 (Black & O’Connor, 
2008; Morelli, V. et al., 2003, Ehrlich, S., 2015; Ali, B. et al., 2008). 
 
Table 4 – Summarized characteristics of eligible trials on ginger’s potentialities. 
 
All mechanisms underlying ginger’s principle therapeutic indications are not clearly 
understood, but the compounds |6|-gingerol and |6|-shogaol have been shown to have a 
number of interesting pharmacological activities, including antipyretic, analgesic, antitussive 
and hypotensive effects (Alternative Medicine Review, 2003, Young, Y. et al., 2005; Ali, B. et 
al., 2008). 
Affections Effects of ginger Literature 
Motion sickness, nausea and 
chemotherapy-induced 
nausea 
Ginger is as effective as many 
traditional antiemetic 
pharmaceuticals 
Schmid, R., et al., (1994) 
Lien, H. et al., (2003) 
Ehrlich, S., (2015) 
Digestion and functional 
dyspepsia 
Acetone extract of ginger and its 
constituents enhanced the gastric 
emptying of charcoal meal in mice 
Hu, M. et al. (2011) 
Yamahara, J. et al., (1990) 
Blood Pressure and Asthma 
Promotes smooth muscle 
relaxation and more elastic blood 
vessels 
Ghayur, M. & Gilani, A. (2005) 
Townsend, E. et al., (2014) 
Cholesterol and Diabetes 
Lowers LDL cholesterol and 
triglycerides while raising HDL (é 
cholesterol excretion) 
Fuhrman, B. et al., (2000) 
Kadnur, S. & Goyal, R. (2005) 
Antimicrobial activity 
Effective against bacteria (Gram-
positive), H. pylori, and fungi 
(Candida albicans) 
Hasan, H. et al., (2012) 
Deba, F. et al., 2008) 
Antiplatelet aggregation 
Ginger extract inhibits platelet 
aggregation and thromboxane-B2 
(TXB2) production in vitro 
Thomson, et al. (2002) 
Osteoarthritis 
Improvement of individuals with 
osteoarthritis of the hip and knee 
Bliddal, H. et al. (2000) 
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ü Motion sickness, nausea and chemotherapy-induced nausea 
  
Ginger has long been used as a remedy to decrease nausea and vomiting associated with 
several conditions, however its mechanism of action is still unknown, but hypothesized that it 
ameliorates the nausea associated with motion sickness by preventing the development of 
gastric dysrhythmias and the elevation of plasma vasopressin (Lien, H. et al., 2003).  
Furthermore, recent evidences refer that ginger’s anti-emetic effect may be linked to its anti-
serotonin effects on both the CNS and gastrointestinal systems (Pongrojpaw, D. et al. 2007). 
 
Several studies suggest that ginger may work better than placebo in reducing some 
symptoms of motion sickness. In one trial, of 80 new sailors who were prone to motion 
sickness, those who took powdered ginger had less vomiting and cold sweats compared to 
those who took placebo (Ehrlich, S., 2015). According to nausea, human studies suggest 
that 1g daily of ginger may reduce nausea and vomiting in pregnant women when used for 
short periods (no longer than 4 days), and found that ginger is better than placebo in 
relieving morning sickness and has no adverse effect on pregnancy outcome (Ehrlich, S., 
2015; Vutyavanich, T. et al., 2001; Pongrojpaw, D. et al. 2007; Willetts, K. et al., 2003). 
Furthermore, a few studies suggest that ginger may reduce the severity and duration of 
nausea and vomiting, during chemotherapy (Zick, S. et al., 2009). Pillai, A. et al. (2011) 
concluded that ginger root powder was effective in reducing the severity of acute and 
delayed chemotherapy-induced nausea and vomiting, as additional therapy to Ondansetron 
and Dexamethasone (standard antiemetics used in the study) in patients receiving high 
emetogenic chemotherapy. 
 
In another trial, 13 volunteers with a history of motion sickness underwent circular vection, 
during which nausea (scored 0-3, i.e., none to severe), electrogastrographic recordings, and 
plasma vasopressin levels were assessed with or without ginger pre-treatment in a 
crossover-design, double-blind, randomized placebo-controlled study. Pre-treatment with 
ginger (1,000 and 2,000 mg) reduced the nausea, tachygastria, and plasma vasopressin. 
Ginger also prolonged the latency before nausea onset and shortened the recovery time 
after vection cessation, which implies that ginger may act as a novel agent in the prevention 
and treatment of motion sickness (Lien, H. et al., 2003). 
 
Other double-blind studies have been performed, and demonstrate a positive effect of ginger 
on motion sickness, shown to be as effective as many traditional antiemetic pharmaceuticals 
for seasickness such as domperidone, dimenhydrinate, scopolamine, cinnarizine, cyclizine 
and meclozine (Schmid, R. et al., 1994). 
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Schmid, R. et al., (1994) performed a study on a total of 1475 tourist volunteers who were 
joining a whale safari in Norway, in order to evaluate and compare the efficacy and 
tolerability of 7 commonly used drugs for the prevention of seasickness  - cinnarizine, 
cinnarizine + domperidone, cyclizine, dimenhydrinate + caffeine, ginger root, meclozine + 
caffeine and scopolamine. The passengers were asked to take the study medications about 
2 hours prior to departure of the boat, done under supervision, and to return completed 
questionnaires. 
 
Table 5 – Drug efficacy (Schimd, R. et al., 1994). 
Seasickness (%) 
Drugs None Slight/Moderate Severe/Vomiting Vomiting 
Cinnarizine 80.3 10.1 9.6 7.6 
Cinnarizine/Domperidone 77.7 16.6 5.7 4.8 
Cyclizine 80.7 9.1 10.2 6.3 
Dimenhydrinate/Caffeine 81.4 10.8 7.8 4.1 
Ginger root 78.3 12.3 9.4 7.9 
Meclozine/caffeine 79.1 13.1 7.8 5.2 
Scopolamine 75.2 11.5 13.3 10.2 
 
Table 5 shows that in the various treatment groups, 9.1%-16.6% revealed at least slight 
seasickness, with the rates for vomiting varying from 4.1%-10.2%. Furthermore, those using 
scopolamine had tendency to more illness in comparison to the other treatment groups, and 
also reported visual problems slightly more frequent than with other medications. None of 
the various studied medications offered complete protection against seasickness, only 
scopolamine showing less efficacy (Schmid, R. et al., 1994). Ginger was shown to be an 
agent almost as potent as the others tested, and particularly fascinating, as it is said not to 
act on the Central Nervous System, but on the Gastric System (Holtmann, S. et al., 1989). 
 
ü Digestion and functional dyspepsia 
 
Ginger root powder has long been used in traditional medicine for alleviating the symptoms 
of Gastro Intestinal (GI) illnesses. In this context, Yamahara, J. et al., (1990) found that the 
acetone extract of ginger and its constituents enhanced the gastric emptying of charcoal 
meal in mice. 
 
Recently, Hu, M. et al. (2011) focused on the evaluation of ginger effects on gastric motility 
and emptying, abdominal symptoms and hormones that influence motility in dyspepsia. 
Eleven patients with functional dyspepsia were studied twice in a randomized double-blind 
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manner (after an 8-hour fast, they ingested 3 ginger capsules (1.2g in total) or placebo, 
followed after 1 hour by 500 ml low-nutrient soup. 
 
Figures 3 and 4 – Fig. 3 – Gastric emptying after ginger and placebo intake in patients with functional 
dyspepsia who consumed 500 ml of low-nutrient soup; Fig. 4 – Frequency of antral contractions after 
ginger and placebo in patients with functional dyspepsia (Hu, M. et al., 2011). 
 
 
Fig.3    Fig.4 
 
As can be seen on Figure 3, gastric emptying was more rapid after ginger intake than with 
placebo |median (range) half-emptying time (T50: 12.3 (8.5-17.0 minutes)| vs. 16.1 (8.3-22.6 
minutes), and there was a trend for smaller antral area after ginger. Figure 4 demonstrates 
that there was a trend for a higher frequency of antral contractions after ginger intake. In 
summary, it was confirmed that the acceleration of gastric emptying by ginger was possible 
in patients with functional dyspepsia, although further studies on specific groups (as for 
example performed in patients with known delayed gastric emptying), are required in order 
to determine whether ginger can be a useful therapeutic approach. 
 
ü Blood Pressure and Asthma 
 
Many studies, mainly performed with rats, have suggested that ginger extracts exert many 
direct and indirect effects on blood pressure and heart rate, as the use of ginger in 
cardiovascular diseases has long been known (Chen, Z. et al., 2009). 
 
Lately, Ghayur, M. & Gilani, A. (2005) performed a study to investigate the blood pressure 
(BP) lowering potential of the crude extract of fresh ginger in anesthetized rats, the effect of 
ginger extract on guinea pig atria and the effect of the extract on the rabbit aorta in 
comparison to a commonly prescribed antihypertensive (verapamil), as well as the possible 
mechanism of action was explored using isolated cardiovascular preparations. 
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Figures 5 and 6 – Fig. 5 - Typical tracing of showing the hypotensive effect of ginger crude extract 
(Zo.Cr) in comparison to norepinephrine (NE) and acetylcholine (ACh) on blood pressure (BP) in 
anesthetized rats; Fig. 6 – Typical tracing showing the cardiodepressant effect of the ginger crude 
extract (Zo.Cr) in comparison to verapamil in isolated guinea pig atrium (Ghayur, M. & Gilani, A. 
(2005). 
 
Fig. 5         Fig. 6 
 
The aqueous-methanolic extract of fresh ginger induced a dose-dependent (0.3-3.0 mg/kg) 
fall in blood pressure of rats under anesthesia (Figure 5). On the other hand, in the guinea 
pig paired atria, the extract caused an inhibitory effect on the spontaneous force and beating 
rate of atrial contractions (Figure 6). This fact may be correlated with the possible 
mechanism of action by which ginger may act, as in the isolated guinea pig paired atria the 
extract decreased the force and rate of spontaneous atrial contractions in a dose-dependent 
manner, similar to verapamil, known as a standard calcium antagonist (Chen, Z., et al., 
2009).  
 
Regarding the rabbit aorta, routinely used for the screening of antihypertensive Calcium 
Channel Blockers (CCBs), the CCB effect mediated by the crude extract in the vascular 
tissues was found to be more potent than the effect exhibited in cardiac tissue. In addition, 
the fresh ginger extract relaxed the phenylephrine-induced vascular contraction at a dose 10 
times higher than that required against K+-induced contraction. Also, CCB activity was 
confirmed when the crude extract shifted the calcium-dose-response curves to the right 
similar to the effect of verapamil. In conclusion, these data indicate that the arterial blood 
pressure-lowering effect of ginger is mediated through the blockade of voltage-dependent 
calcium channels and effective, and that ginger may act as a potent vasodilator. 
 
Natural herbal remedies, including ginger, have long been used, as well, to treat respiratory 
conditions. Many individuals suffering from asthma (exaggerated airway narrowing and 
increased airway inflammation) search for herbal therapies in order to self-treat their asthma 
symptoms, however little is known concerning how these compounds work in the airways 
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(Townsend, E. et al., 2014). With this in mind, Townsend, E. et al., (2014) conducted a study 
in order to determine whether ginger extract compounds (|6|-gingerol, |8|-gingerol or |6|-
shogaol) potentiate β-agonist-induced airway smooth muscle (ASM) relaxation, (as β-
agonists represent the first-line therapy to alleviate asthma symptoms by acutely relaxing the 
airways), and if so, define the mechanism(s) of action responsible for this potentiation. 
 
For the study, the researchers used human ASM that contracted in organ baths, and guinea 
pig tracheal rings. The tissues were relaxed dose-dependently with a β-agonist 
(isoproterenol) in the presence of several vehicles (|6|-gingerol, |8|-gingerol or |6|-shogaol 
100 µM), and whose relaxation results can be seen on Table 6. Cellular experiments used 
primary human ASM cells, and purified phosphodiesterase (PDE) 4 or phospholipase C-β 
enzyme was used to assess the inhibitory activity of ginger components using fluorescent 
assays. 
 
Table 6 – Summary of the effects of ginger components on isoproterenol half-maximal effective 
concentration ASM relaxation contracted by acetylcholine (Townsend, E. et al., 2014). 
Isoproterenol EC50 (nM) 
 Human ASM Guinea Pig ASM 
Vehicle (0.2% DMSO) 28.5±2.6 8.9±1.9 
|6|-gingerol (100 µM) 1.7±0.6 1.5±0.3 
|8|-gingerol (100 µM) 2.1±0.5 1.2±0.2 
|6|-shogaol (100 µM) 1.1±0.5 0.8±0.1 
|10|-gingerol (100 µM) - 5.8±2.1 
U-73122 (5 µM) - 3.2±1.0 
Definition of abbreviations: ASM – airway smooth muscle, DMSO – dimethyl sulfoxide, EC50 – half-
maximal effective concentration. 
 
Table 6 lists the results for human and guinea pig isoproterenol-induced relaxation. In 
human ASM tissue contracted with acetylcholine (ACh), 100 µM of |6|-gingerol, |8|-gingerol 
or |6|-shogaol revealed minimal relaxation when compared with vehicle controls (0.2% 
DMSO). As all tissues received either a single treatment of vehicle (0.2% DMSO) or 100 µM 
of |6|-gingerol, |8|-gingerol or |6|-shogaol concurrently with the 300-pM isoproterenol dose, 
one can say that, in comparison to the vehicle, all active components of ginger significantly 
potentiated the isoproterenol-induced relaxation oh human ASM. Furthermore, it was 
observed that |6|-shogaol was the greatest potentiator of relaxation. Similar results were 
verified in guinea pig ASM tissues contracted with ACh and subjected to identical 
treatments. 
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The mechanisms of action, underlying the action of the tested ginger components, can be 
seen on Figure 7. In summary, |6|-gingerol, |8|-gingerol, and |6|-shogaol potentiate β-
agonist-induced relaxation of the airway smooth muscle by inhibiting both 
phosphodiesterase 4D (PDE4) and phosphatidylinositol-specific phospholipase C isoform β 
(PLC β), leading to the downstream regulation of contractile proteins, which suggest that 
natural compounds can work in combination with traditional asthma prescriptions in order to 
relieve its symptoms and exacerbations. 
 
Figure 7 – Mechanisms of action of the isolated components of ginger, |6|-gingerol, |8|-gingerol and 
|6|-shogaol, with multiple intracellular targets that potentiate β-agonist–induced relaxation in ASM 
(adapted from Townsend, E. et al., 2014). 
  
Definition of abbreviations: DAG – Diacylglycerol, Gq – G protein-coupled receptor type q, PIP2 – 
Phosphatidylinositol-4,5-bisphosphate, PLC β – phospholipase C isoform β, MLC20 – myosin light 
chain 20, MLCK – MLC kinase, MLCP – MLC phosphatase, cAMP – 3’-,5’-cyclic adenosine 
monophosphate, PKA – protein kinase A, IP3 – inositol triphosphate, PKC – protein kinase C, CPI-17 
– 17 kD protein kinase C-potentiated inhibitory protein of type 1 protein phosphatase, RhoA – Ros 
homolog gene family member A, ROK – Ros homolog gene family kinase (Townsend, E. et al., 2014). 
 
ü Cholesterol and Diabetes 
 
Coronary artery disease may develop as a result of various risk factors, including increased 
plasma Low Density Lipoprotein (LDL) levels, commonly known as “bad cholesterol”, as well 
as LDL modifications, such as oxidation or aggregation. The consumption of nutrients rich in 
phenolic antioxidants have been shown to attenuate the development of atherosclerosis 
(Fuhrman, B. et al., 2000, Ojewole, J., 2006). 
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A study conducted with apolipoprotein E-deficient mice, which develop atherosclerotic 
plaques which resemble the lesions found in humans, revealed a significant reduction (76%) 
in cellular cholesterol biosynthesis rate in peritoneal macrophages derived from the mice 
that consumed a 250 µg/day of ginger extract for 10 weeks compared to those from controls, 
both in vivo and in vitro, revealing a reduction on the levels of triglycerides in plasma and 
LDL by 27% and 58%, respectively. Additionally, this study confirmed that ginger extract, 
whose mainly antioxidative active principles were gingerols and shogaols, as well as some 
related phenolic ketone derivatives, had exhibited a direct antioxidative effect against LDL 
oxidation (Fuhrman et al., 2000). Human trials are required, as this potent ginger activity is 
still humanly unexplored. 
 
As hyperlipidemia is generally associated with elevated levels of blood glucose and insulin 
levels (diabetes), Kadnur, S. & Goyal, R. (2005) undertook a study in order to explore the 
possible beneficial effects of ginger in fructose-induced hyperlipidemia, hyperinsulinemia 
and hyperglycemia in four groups of rats. Each group of animals was administered vehicle or 
drugs daily for 3 weeks, and a normal diet: 
Group I – normal diet + water ad libitum + vehicle solvent; 
Group II – normal diet + water with 10% fructose + vehicle solvent (control) 
Group III – normal diet + water with 10% fructose + methanolic extract of ginger (250mg/kg) 
Group IV – normal diet + water with 10% fructose + ethyl acetate extract of ginger (250mg/kg) 
 
Table 7 – Evaluation of ginger extracts on various parameters in fructose-induced hyperlipidemia in 
rats (values are mean ± SE of 6 rats in each group) (Kadnur, S. & Goyal, R., 2005). 
Groups Tested 
Serum Parameters 
Normal 
Control 
Hyperlipidemia 
Control 
Methanolic 
ginger extract 
Ethyl acetate 
ginger extract 
Glucose (mg/dl) 86.5±1.9 116.1±3.4 95.1±1.7 114.1±2.5 
Insulin (µU/ml) 23.6±1.2 41.3±0.9 34.0±1.1 41.0±0.6 
Cholesterol (mg/dl) 73.0±1.2 106.1±1.4 84.2±1.5 92.7±1.0 
Triglycerides (mg/dl) 69.7±1.2 152.0±3.9 88.2±2.8 111.1±2.3 
HDL cholesterol (mg/dl) 17.5±0.6 19.3±0.5 17.4±0.4 17.6±0.4 
LDL-cholesterol (mg/dl) 41.5±1.4 56.3±1.3 49.0±1.9 52.9±0.6 
VLDL-cholesterol (mg/dl) 13.9±0.2 30.3±0.7 17.6±0.5 22.2±0.4 
Body weight (g/rat) 243.3±3.3 378.3±3.0 326.7±2.1 335.0±2.2 
 
The results of the study, summarized in Table 7, demonstrate that the treatment with an 
extract of Zingiber officinalis is effective in reducing both elevated lipid profile and elevated 
glucose levels, having the methanolic extract of ginger clearly demonstrated a better 
response as it also prevented partially but significantly the elevated insulin levels in fructose-
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fed rats. Additionally, the results show significant reduction in body weight on treatment with 
both extracts of ginger, which suggest that ginger may be useful in conditions of Syndrome-
X (Metabolic Syndrome) and associated disorders, as it can reduce the elevated 
hypertriglyceride, VLDL-cholesterol levels and hyperinsulinemia (Gonlachanvit, S. et al., 
2003). Recently, Ojewole, J. (2006) performed a study on diabetic rats, and compared the 
action of chlorpropamide (reference hypoglycemic agent used in the study) with the 
ethanolic extract of Z. officinalis dried rhizomes, and found that both produced significant 
reductions in the blood glucose levels of fasted normal and fasted streptozotocin-induced 
diabetes mellitus rats. 
 
ü Antimicrobial activity 
 
The antimicrobial activity against both bacteria and fungi by Zingiber officinalis has been 
described by several studies, which attribute this double-action to the presence of isolated 
phenolic compounds in ginger’s root, both gingerol and shogaol, lipid-soluble phenolic 
compounds (Hasan, H. et al., 2012, Park, M. et al., 2008). 
 
Bajpai, V. et al., (2009) as well as other researchers, are in agreement with the previous 
statement, and refer that it seems reasonable to assume that the antimicrobial mode of 
action might be related to the phenolic compounds present in ginger, as most of the studies 
conducted on their mechanism of action have focused on their effects on cellular 
membranes (Bajpai, V. et al., 2009; Hasan, H. et al., 2012). Furthermore, they refer that 
phenolic compounds attack cell walls and cell membranes (affecting their permeability and 
release of intracellular constituents like ribose, for instance), and also interfere with 
membrane functions (electron transport, nutrient uptake, protein, nucleic acid synthesis and 
enzyme activity), highlighting that these phenolic compounds might have several invasive 
targets which can lead to the inhibition of microbial pathogens (Bajpai, V. et al., 2009). 
 
Table 8 – Antimicrobial activities of the methanolic extract of Zingiber officinalis rhizome and methanol 
(negative control) (Hasan, H. et al., 2012). 
 Inhibition zone diameter (mm) at different concentrations of the MeOH extract 
(mg/dl) 
Tested Microorganisms 50 25 12.5 6.25 3.1 
Gram-positive 
Staphylococcus epidermidis 
Staphylococcus aureus 
 
16.5 
17 
 
12 
16 
 
- 
14 
 
- 
- 
 
- 
- 
Gram-negative 
Proteus sp. 
Klebsiella sp. 
 
12.5 
14 
 
- 
10 
 
- 
- 
 
- 
- 
 
- 
- 
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Table 8 results on antimicrobial activities of the extract of Zingiber officinalis clearly show 
that this extract is more effective against Gram-positive bacteria when compared to the 
Gram-negative ones in vitro, assessed by the presence or absence of inhibition zones, 
whose higher resistance can be explained by the complexity of the Gram-negative bacteria 
cell wall, whose external membrane yields highly hydrophilic surfaces whereas the negative 
charge present on the surface of the Gram-positive bacteria wall may reduce their resistance 
to antibacterial compounds (Hasan, H. et al., 2012; Michielin et al., 2009). 
 
The results on the antifungal activity assay showed that the extract of ginger also displays 
inhibitory effects on the growth of Candida albicans, which may be a result of the action of 
the monoterpenes present in the extract, reported to have a wide range of antifungal activity, 
through the disruption of the fungal membrane integrity (Hasan, H. et al., 2012; Deba, F. et 
al., 2008). 
 
Recently, Mahady, G. et al., (2003) tested the in vitro effects of ginger on 19 strains of 
Helicobacter pylori (primary etiological agent associated with dyspepsia, peptic ulcer disease 
and development of gastric and colon cancers), including 5 CagA+ strains, and the obtained 
results are listed in Table 9. 
 
Table 9 – Minimum inhibitory concentrations of ginger extracts and gingerols in 5 CagA+ strains of H. 
pylori (Mahady, G. et al., 2003). 
 Minimum inhibitory concentrations and 5 CagA+ strains of H. pylori 
HP Strain 43504 M23-3 GTD7-13 G1-1 SS1 ATCC 
Ginger root-MeOH 6.25 25.0 6.25 6.25 25.0 
Methanol-F2 0.78 6.25 1.56 0.78 6.25 
|6|-gingerol 6.25 12.0 12.5 3.125 6.25 
|8|-gingerol 3.125 6.25 6.25 3.125 6.25 
|10|-gingerol 1.56 6.25 1.56 1.56 6.25 
|6|-shogaol 12.5 25.0 12.5 12.5 25.0 
*CagA+ is the strain-specific H. pylori gene that has been linked to the development of premalignant 
and malignant histological lesions, and infections caused by CagA+ strains significantly increase the 
risk of developing severe gastric inflammation, atrophic gastritis and noncardia gastric 
adenocarcinoma (Mahady, G. et al., 2003). 
Escherichia coli 
Enterococcus sp. 
Pseudomonas florescent 
12 
14.5 
10 
- 
12 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Fungi 
Candida albicans 
 
13.5 
 
- 
 
- 
 
- 
 
Methanol (negative control) - - - -  
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The researchers indicated that the methanolic extract of ginger rhizome inhibited the growth 
of all 19 strains of H. pylori in vitro, with a minimum inhibitory concentration (MIC) range of 
6.25 to 50 µg/ml. Furthermore, one fraction of the crude extract, containing the gingerols, 
was active and inhibited the growth of all H. pylori strains with a MIC range of 0.78 to 12.5 
µg/ml, with significant activity against the CagA+ strains, results that may contribute to 
support the chemopreventive effects of ginger. 
 
Recently, Zick, S. et al. (2011) evaluated the effects of ginger in colon mucosa in people at 
normal risk for colorectal cancer, and found that ginger appears to potentially decrease 
eicosanoid levels (inflammatory products), through the inhibition of their synthesis from the 
arachidonic acid, and thus reduce inflammation, but warrant further study due to small 
sample size. 
 
Park, M. et al. (2008) also found that |10|-gingerol present in ginger’s rhizome evidenced 
potent antibacterial activities in vitro against anaerobic bacteria associated with periodontitis 
of the human oral cavity by activity-guided assays. 
 
ü Antiplatelet aggregation 
 
Ginger has shown to exhibit antithrombotic activity, as its extract was found to inhibit platelet 
aggregation and thromboxane-B2 (TXB2) production in vitro (Srivastava, K. & Mustafa, T., 
1989; Nicoll, R. & Henein, M., 2007). 
 
Recently, Thomson, M. et al., (2002) investigated the ex vivo effect of an aqueous extract of 
raw ginger on the synthesis of thromboxane-B2 (TXB2), prostaglandin-E2 (PGE2), cholesterol 
and triglyceride levels in the serum of normal rats, using two routes of administration – oral 
and intraperitoneal (IP), as well as two doses (50 mg/kg and 500 mg/kg) in a four-week trial. 
 
Figures 8 and 9 – Fig. 8 – Effect of aqueous extracts of ginger on the serum levels of PGE2 in rats. 
*significantly different from control (normal saline) using Student’s t-test. Fig. 9 – Effect of aqueous 
extracts of ginger on the serum levels of TXB2 in rats. *significantly different from control (normal 
saline) using Student’s t-test (Thomson, M. et al., 2002). 
 
Fig. 8 Fig. 9 
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Figures 8 and 9 show the effects of the administration of the aqueous extract of ginger on 
the synthesis of PGE2 and TXB2. The oral administration of ginger, at low doses (50mg/kg), 
significantly reduced the levels of serum PGE2. However, high oral dose intake of ginger 
(500 mg/kg) was more effective in reducing the synthesis of PGE2. Additionally, PGE2 levels 
were significantly lower than the saline control in rats given 500mg/kg ginger extract either 
orally or IP. It can also be seen that the higher oral dose of ginger (500mg/kg) had 
significantly reduced TXB2 levels in the serum, rather than the lower dose. To summarize, 
the unique ability of ginger to inhibit the synthesis of both PGE2 and TXB2 is clinically 
important, because its daily intake for a prolonged period will neither lead to side-effects or 
complications as normally occurs with non-steroidal anti-inflammatory drugs (NSAIDs). 
 
ü Osteoarthritis 
 
Traditional medicine has used ginger for centuries to reduce inflammation, and there is 
some evidence that ginger may help reduce pain from osteoarthritis (OA). Preclinical 
research has shown that both gingerols and shogaols present in ginger extract act as 
cyclooxygenase inhibitors of (COX), particularly the inducible form of COX (COX-2), rather 
than the constitutive form (COX-1), as well as leukotriene synthesis (explained by the action 
of ginger inhibiting lipooxygenase) and production of pro-inflammatory cytokines in vitro 
(Bartels, E. et al., 2015), Black & O’Connor, 2008; Morelli, V. et al., 2003; Chrubasik, J. et 
al., 2007). In addition, Black & O’Connor (2008) found that 6-gingerol and ginger extracts 
acutely reduce paw edema and pain behaviors in rodents within 30 minutes. 
 
Ginger and/or its constituents are thought to act both peripherally, by inhibiting the release of 
prostaglandins (PGs) and leukotrienes (LKs), and centrally, potentially by interacting with a 
vanilloid receptor, which is known to play a role in processing nociceptive signals (Black & 
O’Connor, 2008; Cortright, Krause, & Broom, 2007; Gregory, P. et al., 2008). 
 
Bartels, E. et al., (2015) conducted a study with the aim of assessing the clinical efficacy and 
safety of oral ginger for symptomatic treatment of osteoarthritis (OA), whose inclusion 
criteria were randomized controlled trials comparing oral ginger treatment with placebo in 
OA patients aged above 18, and the outcomes were measured by the reduction in pain and 
reduction in disability. The authors found that after ginger intake, a statistically relevant pain 
reduction SMD = -0.30 (95% CI), as well a statistically significant reduction in disability SMD 
= -0.22 (95% CI) were seen both in favour of ginger. Ginger was modestly efficient and 
reasonably safe for treatment of osteoarthritis. 
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Recently, Naderi, Z. et al., (2015) conducted a study whose aim of investigation was to 
examine the effect of ginger powder supplementation on some inflammatory markers in 
patients suffering from knee osteoarthritis, in a double-blind randomized placebo-controlled 
clinical trial with a follow-up period of 3 months conducted on 100 outpatients with 
moderately painful knee osteoarthritis. Patients were randomly divided into two groups: 
ginger group (GG) and placebo group (PG), and both groups received two identical capsules 
on a daily basis for 3 months. Each ginger capsule contained 500 mg of ginger powder, 
whereas the placebo contained 500 mg of starch, with serum samples being collected prior 
and after the intervention, which can be observed in Table 10. Serum concentration of nitric 
oxide (NO) and hs-C-reactive protein (hs-CRP) were measured using enzyme-linked 
immunosorbent assay kits, and no significant differences between both groups in terms of 
inflammatory markers (i.e. NO and hs-CRP) were found prior to the trial. 
 
Table 10 - Comparison of mean of NO and CRP concentration in both ginger and placebo groups 
prior to and after intervention (Naderi, Z. et al., 2015).  
  
Variables Ginger group Placebo group pa 
Energy (kcal/dl) 
Prior to 
After  
 
1904.2±325.4 
2010.4±401.0 
 
1859.7±272.2 
1997.4±213.1 
 
0.6 
0.3 
Cholesterol (mg/dl) 
Prior to 
After  
 
302.02±102.82 
295.02±87.82 
 
310.21±123.02 
301.02±95.12 
 
0.08 
0.6 
NO (µmol/L) 
Prior to 
After 
Change 
 
29.02±0.82 
26.02±1.82 
-3.0±0.72 
 
29.21±1.02 
27.02±0.32 
-2.01±0.19 
 
0.53 
<0.001 
<0.001 
CRP (mg/L) 
Prior to 
After 
Change  
 
11.06±1.43 
8.47±1.62 
-2.58±1.47 
 
11.21±1.20 
9.66±1.31 
-1.54±1.12 
 
0.56 
<0.001 
<0.001 
 
Definition of abbreviations: CRP – C-Reactive Protein, NO – Nitric Oxide, pa – Student t test. 
 
Table 10 presents the effect of ginger and placebo (starch) on CRP and NO of the patients 
at the beginning of the study and 3 months after the study. As can be seen, there was no 
significant difference between the two groups in CRP and NO concentrations prior to the 
intervention. However, after supplementation with ginger, a significant decrease was 
observed in serum concentration of CRP and NO in the GG, but not in the other group. At 
the end of the study, both CRP and NO concentrations decreased more in the experimental 
group rather the control group. Furthermore, no statistically significant difference was found 
between pre- and post-intervention parameters for daily energy. 
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In conclusion, this study found that in patients who suffered from moderate knee OA, the 
serum concentration of CRP and NO 3 months after ginger supplementation was 
significantly different from the data obtained at the beginning of the study, and Naderi, Z. et 
al. (2015) referred that the possible mechanism by which ginger reduces inflammation in 
patients with OA is summarized as follows: activation of synovial cells in the joints leads to 
the release of two key cytokines involved in the inflammation and degradation of joints, TNF-
α and IL-1β. Both mediators induce NF-kβ, which is a ubiquitous eukaryotic transcription 
factor with a critical role in inflammatory pathways. This nuclear factor brings about 
inflammation by activating iNOS, COX-2 pathway, and lipoxygenase pathway and by 
inducing the secretion of inflammatory cytokines. The gingerols and shogaols present in 
ginger are the compounds responsible for the decrease in the two pro-inflammatory factors 
of TNF-α and IL-1β in osteoarthritic cartilage. In synoviocytes, these compounds decrease 
the IL-1β- or TNF-α-induced expression of TNF-α mRNA and protein, the TNF-α-induced 
production of COX2, and the TNF-α-induced activation of the NF-kβ. In addition, these vital 
compounds suppress the synthesis of prostaglandin (PG) and leukotriene (LK) by inhibiting 
the COX-2 and lipoxygenase pathways and also inflammation-involved pathways, so this 
way, they can diminish the inflammation. 
 
In another study conducted by Zakeri, Z. et al. (2011), the authors evaluated the effects of 
ginger extract on knee pain, stiffness and difficulty in patients with knee OA, and found that 
pain reduction was more significant in ginger group than placebo, and reduction in morning 
stiffness and difficulty were statistically greater in the ginger group, rather than the placebo 
group. Additionally, patients with less duration of the disease showed more improvement, 
which suggests that if the treatment is started at an earlier stage of the disease, before the 
formation of complete knee joint destruction, the results will be much better. 
 
Due to the previously referred strong anti-inflammatory and antioxidant activities exerted 
from ginger, Shukla, Y. & Singh, M. (2007) reviewed several articles on its anti-carcinogenic 
and anti-mutagenic activities, and found that a significant number of in vitro and laboratory 
animal studies provide substantial evidences that ginger and its organic pungent vallinoid 
compounds (mainly |6|-gingerol and |6|-paradol, shogaols and zingerone) are effective 
inhibitors of the carcinogenic process, previously confirmed by Surh, Y. et al. (1998), and 
recently by Kim, M. et al. (2010). 
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Chapter V – Traditional Chinese Medicine concepts and ginger (jiang) applications 
 
Traditional Chinese Medicine (TCM), originated in ancient China, has evolved over the 
years, and it encompasses many different practices, including acupuncture, moxibustion 
(burning of an herb above the skin to apply heat to acupuncture points), Chinese herbal 
Medicine, tui na (Chinese Therapeutic Massage), dietary therapy and mind practices, such 
as qi gong (prevention practice that combines specific movements/postures, coordinated 
breathing and mental focus). TCM practitioners mainly use these techniques to prevent and 
treat health problems (Greten, H., 2007; NCCAM, 2009; Hempen, C. & Chow, V., 2006). 
 
The ancient beliefs on which TCM is based include the following concepts, which are of 
interest in understanding the history of TCM (NCCAM, 2009; Nong, S., 2015; Greten, H. 
2010; Hempen, C. & Chow, V., 2006):  
 
ü The human being is a part of an interwoven network of cosmic energies, as “man is part 
of the holistic entity, and should be analysed or interpreted with reference to the whole”,  
 
ü   Harmony between two opposing yet complementary forces, called Yin and Yang, 
supports health, and disease results from an imbalance between these two forces. Yin 
and Yang can describe two relative aspects of the same phenomena, such as for 
example “Yin representing the shadier side of a slope, and Yang the sunnier side”, or 
they can describe two different objects like sky and earth. 
ü    The Five Elements Theory (Figure 10) — wood (creation of potential), fire 
(transformation of potential into function), earth, metal (relative lack of energy), and 
water (regeneration) — which symbolically represent all natural phenomena, including 
the stages of human life, and explain the functioning of the body and how it changes 
during disease. 
Figure 10 – The Five Element spectrum – regulative sinus curve (Greten, H., 2007). 
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ü Qi, is the vital energy constituting the human body, and performs multiple functions in 
maintaining its health (according to the Heidelberg Model, qi is “the vegetative capacity 
to function of a tissue or organ, which can cause the sensation of pressure, tearing or 
flow”). 
 
ü The System of the 12 Orbs (Jing Mai) – TCM believes there is a distribution network 
for the fundamental substances of qi, blood and body fluids throughout the body, which 
links different areas of our body together, and whose pathways make up a 
comprehensive yet complex body map that supplies vital energy to every part of the 
body. The flow of qi in the Orbs System concentrates in certain areas of the skin’s 
surface, small point areas known as “acupuncture points”. The word “orb” corresponds 
to “a circle or group of diagnostically significant signs and findings grouped and named 
after organs or the region where some of the symptoms take place”. The system of the 
main 12 Orbs, designed on Figure 11, correspond to the Yin (jing) and Yang (luo) organs 
plus the Tricaloric and Pericardium - Yin represented by the liver (hepatic orb), heart 
(cardiac orb), spleen (lienal orb), lungs (pulmonary orb) and kidneys (renal orb), and 
Yang represented by the gall bladder (felleal orb), small intestine (tenuintestinal orb), 
stomach (stomachal orb), large intestine (crassintestinal orb) and bladder (vesicle 
orb). Additionally, there are eight extraordinary vessels (Qi Jing Ba Mai), divergent 
channels (Jing Bie), sinew channels (Jing Jin) and network channels (Luo Mai). 
 
Figure 11 – The 12 Orb System – the Yin & Yang arbogram for diagnosis (Greten, H., 2010). 
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Focusing on the Chinese Herbal Medicine, the Chinese Materia Medica (a pharmacological 
reference book used by TCM practitioners) describes thousands of medicinal substances - 
primarily plants, but also some minerals and animal products, in which different parts of 
plants, such as leaves, roots, stems, flowers, and seeds, are reported to be used. In TCM 
herbs are often combined in formulas and given as teas, capsules, liquid extracts, granules, 
or powders (NCCAM, 2009; Nong, S., 2015; Greten, H. 2010; Hempen, C. & Chow, V., 
2006).  
 
Herbal medicines used in TCM are sometimes marketed in other countries, as well as in 
Portugal, as dietary supplements. The Portuguese Autoridade Nacional do Medicamento e 
Produtos de Saúde (INFARMED, I. P.) regulations for dietary supplements are less 
stringent.  
 
In spite of the widespread use of TCM in China and its use in the West, rigorous scientific 
evidence of its effectiveness is limited, and so, in other countries, people only seek TCM as 
a complementary health approach. TCM can be difficult for researchers to study because its 
treatments are often complex and are based on ideas very different from those of modern 
Western medicine.  Most research studies on TCM have focused on specific techniques, 
primarily acupuncture and Chinese herbal remedies, and there have been many systematic 
reviews of studies on TCM approaches for various conditions. 
 
However, the use of herbal medicine as a pharmacologic modality in improving several 
pathological statuses has received attention from medical science researchers. Ginger 
(Zingiber officinalis), a plant that belongs to the Zingiberaceae family, is indigenous to 
Southeast Asia, and for centuries has been an important ingredient in Chinese and 
Ayurvedic herbal medicines for the treatment of different diseases (Atashak, S., et al., 2014). 
 
Ginger, due to its pungent (spicy) and hot taste, belongs to two of the 19 main groups of 
Chinese pharmacology, specifically the Metagroup I  – Groups I - IX used to treat acute 
infections, that resides in the treatment of the extima (skin, conduits and mucosa), which 
contain pores that retain fluids (Greten, H., 2007). 
 
Furthermore, Ginger belongs to the Group I a) – Liberantia Extimae Acria et Calida as it 
“warms the “centre” and the conduits”, being responsible for the upward liberation of the 
extima, supporting the ascending movement of the functional powers to the extima, acting 
primarily on the Pulmonary Orb (Po) as the extima is activated by this orb. Additionally, this 
warming drug acts on the nose, part of the Po, which normally tends to Algor 
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(environmental cold, commonly described by cold skin, stiff muscles, tearing and localised 
pain with gradual onset). If the pathogenic factor algor (the agent) overcomes the outer 
extimal stage, it enters the intima and may cause deficiencies in several functions, occurring 
the typical course of an algor (“cold”) attack, leading to the six stages of the ALT (Algor 
Laedens Theory). In this case, ginger belongs as well to the Group IX – Tepefacientia 
intimae (the interior warming drugs), having an effect on functional deficits at the minimum 
of the regulative sinus curve, at the transition from Metal to Water, and at the same time, at 
the beginning of the neutral vector (Greten, H., 2007). 
 
Drugs that warm the interior therefore have a stimulating effect on functions, or in Chinese 
Medical language, a suppletive effect on functional powers, counteracting the symptoms of 
the phase Water (regeneration need, renal signs, in yang deficiency) or insufficiencies of the 
Centre (support of the upward going vector) or even warm the surface (Metal). Following 
this, ginger may act as a rescue of devastated yang or yang deficiency (a chronic 
exhaustion condition in which invading cold or infection has reached the interior of the body, 
seen by the production of excessive calor - reactive calor, causing ice-cold feelings 
combined with an extremely fast pulse, cold limbs and cold sweat) warming the Earth 
channels, as well as influencing several other channels (the Cardiac, Pulmonal, Lienal and 
Stomachal orbs). 
 
In Chinese Medicine, ginger’s rhizome is often combined with several principles in order to 
create decoctions that act as extima liberating formulations: 
  
ü Decoctum ramulorum cassiae, composed of ramuli cassiae (50g), r. paeoniae 
albae (40g), r. glycyrrhizae tosta (30g), rh. zingiberis vir. (30g) and fr. jujubae (4-6), 
which “liberates the flesh in algor venti and myalgia”; 
 
ü Decoctum parvum draconis viridis, mainly composed of Decoctum ephedrae, 
(herba ephedrae (50g), ramuli cassiae (40g), s. armeniacae (30g) and r. glycyrrhizae 
(10g)), which “liberates, unfolds, transforms”, except s. armeniacae and plus rh. 
zingiberis, r. paeoniae, rh. pinelliae praeparata, fr. schizandrae and c. cinnamomi, 
which “warms the centre when blocked by pituita and algor” or Decoctum magnum 
draconis viridis mainly composed of Decoctum ephedrae plus gypsum fibrosum, 
rh. zingiberis and fr. jujubae, which “liberates the extima, initiates sweat, cools calor, 
relieves restlessness and malaise, splendor yang”. 
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Chapter VI – Ginger-drug possible interactions 
 
In literature, few ginger-drug interactions have been reported, since it does not interact with 
almost any active principle. 
 
Vaes, L. & Chyka, P. (2000), as well as Weidner, M. & Sigwart, K. (2000), admitted no case 
reports of interactions between ginger and an anticoagulant (warfarin) in rats and humans 
have been identified to date, which has recently been confirmed by Jiang, X. et al. (2006) in 
an open label randomized study on the effect of four herbal medicines on warfarin 
pharmacokinetics and anticoagulant response. Regarding ginger, the study was performed 
in 12 healthy volunteers in 2 clinical trials, who were given 400mg of ginger orally three 
times per day for one week, before taking a single 25mg-dose of warfarin. The results 
indicated that ginger does not exert significant effects on either the blood clotting status or 
pharmacokinetics and dynamics of warfarin. 
 
Still focusing on cardiovascular drugs, Young, H.-Y. et al. (2006) have studied the 
synergistic effect of ginger and an antianginal/antihypertensive drug (nifedipine) on 
antiplatelet aggregation in healthy human volunteers, as well as hypertensive patients, on a 
two-phase trial whose results can be seen on Tables 11 and 12. 
 
Table 11 - Synergistic effect of Ginger and Nifedipine on platelet aggregation in normal volunteers. 
Percentage of inhibition of platelet aggregation 
 Nifedipine Aspirin Nifedipine + Aspirin Ginger Nifedipine + Ginger 
Collagen 20.2±0.7 37.2±0.7 82.8±8.5 35.2±0.8 79.8±0.6 
ADP 22.6±0.6 39.7±0.8 78.2±9.15 37.8±0.8 75.2±0.8 
Epinephrine 23.4±1.0 34.9±0.5 72.2±8.5 35.9±0.7 69.3±0.5 
*Collagen, Adenosine Diphosphate (ADP) and Epinephrine as induced drugs for the measurement of 
platelet aggregation.  
 
Table 12 – Synergistic effect of Ginger, Aspirin and Nifedipine on platelet aggregation in hypertensive 
patients. 
Percentage of inhibition of platelet aggregation 
 Nifedipine Nifedipine + Aspirin Nifedipine + Ginger 
Collagen 20.5±0.7 65.2±0.7 64.2±0.5 
ADP 22.3±0.6 64.6±1.1 63.8±0.4 
Epinephrine 19.2±1.0 62.8±1.1 61.1±0.8 
* Collagen, Adenosine Diphosphate (ADP) and Epinephrine as induced drugs for the measurement of 
platelet aggregation. 
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The data obtained from the study support that the percentage of platelet aggregation 
induced by collagen, ADP and epinephrine in hypertensive patients was higher than that in 
healthy volunteers. Additionally, either aspirin or ginger could potentiate the anti-platelet 
aggregation effect of Nifedipine both in normal and hypertensive patients, which suggest that 
ginger and Nifedipine have a synergistic effect on anti-platelet aggregation. Furthermore, 
they recommended the combination of 1g of ginger with 10mg of nifedipine per day as it 
would be valuable in cardiovascular and cerebrovascular complication due to platelet 
aggregation (Young, H.-Y. et al., 2006). 
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Chapter VI - Conclusion 
 
Plant based secondary metabolites, such as plant extracts and essential oils, are widely 
used in the food industry, and considered as GRAS (Generally Recognised as Safe). 
Several publications have documented the numerous potential activities of the root extract 
from Zingiber officinalis, and were fully and concisely described on this manuscript. 
 
The papers and journals reviewed provide another example of how it may be possible to 
explain the action(s) of western medicine in terms of conventional biochemistry and 
pharmacology. Ginger and many of its chemical constituents have strong properties, and 
especially, anti-inflammatory actions. As several metabolic diseases and age-related 
degenerative disorders are closely associated with inflammatory processes in the body, the 
user of either ginger or one or more of its active compounds as a source of anti-inflammatory 
to fight inflammation really warrants further attention. Additionally, more studies are also 
required on the kinetics of ginger and its components, and on the effects of their 
consumption over a long period of time. 
 
The fourteen-day trial allowed us to know that ginger is almost as effective as a commonly 
prescribed NSAID for the treatment of muscular pain (ibuprofen). Nevertheless, further trials 
in humans are required to determine the real efficacy of ginger (or one or more of its 
compounds) and to establish if there are any adverse effects. 
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